VANCOUVER—Cholinesterase inhibitor treatment in patients with mild Alzheimer’s disease may lead to greater improvement in cognitive performance than cholinesterase inhibitor treatment in patients with moderate Alzheimer’s disease, researchers reported at the 2012 Alzheimer’s Association International Conference.
“Death of cholinergic neurons in patients with Alzheimer’s disease correlates with severity of cognitive impairment,” said Sarah Wakefield, doctoral student at the University of Sheffield in the United Kingdom, and colleagues.
More Headlines